Co-Authors
This is a "connection" page, showing publications co-authored by Ahmed GAD and NABIL AHMED.
Connection Strength
2.072
-
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells. Sci Adv. 2025 Jan 10; 11(2):eadq8114.
Score: 0.983
-
Realism and pragmatism in developing an effective chimeric antigen receptor T-cell product for solid cancers. Cytotherapy. 2016 11; 18(11):1382-1392.
Score: 0.551
-
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial. Nat Cancer. 2024 Jun; 5(6):880-894.
Score: 0.234
-
A checkpoint reversal receptor mediates bipartite activation and enhances CAR T-cell function. Cancer Res Commun. 2025 Feb 20.
Score: 0.062
-
ZP4: A novel target for CAR-T cell therapy in triple negative breast cancer. Mol Ther. 2025 Feb 20.
Score: 0.062
-
Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma. Nat Med. 2021 Jun; 27(6):1117-1120.
Score: 0.048
-
Targeting hydrogen sulphide signaling in breast cancer. J Adv Res. 2021 Jan; 27:177-190.
Score: 0.045
-
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma. Nat Med. 2020 05; 26(5):720-731.
Score: 0.044
-
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression. Leukemia. 2021 01; 35(1):75-89.
Score: 0.044